zyprexa zydis
pharmaco (nz) ltd - olanzapine 10mg - wafer - 10 mg - active: olanzapine 10mg excipient: aspartame gelatin mannitol purified water sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate - zyprexa is indicated for the treatment of schizophrenia and related psychoses.
zyprexa zydis
pharmaco (nz) ltd - olanzapine 15mg - wafer - 15 mg - active: olanzapine 15mg excipient: aspartame gelatin mannitol purified water sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate - zyprexa is indicated for the treatment of schizophrenia and related psychoses.
zyprexa zydis
pharmaco (nz) ltd - olanzapine 20mg - wafer - 20 mg - active: olanzapine 20mg excipient: aspartame gelatin mannitol purified water sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate - zyprexa is indicated for the treatment of schizophrenia and related psychoses.
zyprexa zydis
pharmaco (nz) ltd - olanzapine 5mg - wafer - 5 mg - active: olanzapine 5mg excipient: aspartame gelatin mannitol purified water sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate - zyprexa is indicated for the treatment of schizophrenia and related psychoses.
zyprexa im
pharmaco (nz) ltd - olanzapine 10mg (there is a 10% overfill of powder) - powder for injection - 10 mg - active: olanzapine 10mg (there is a 10% overfill of powder) excipient: lactose monohydrate tartaric acid sodium chloride water for injection - zyprexa im is indicated for the rapid control of agitation and disturbed behaviours in patients with schizophrenia and related psychoses and in patients with acute mania associated with bipolar i disorder, when oral therapy is not appropriate.
gamunex
pharmaco (nz) ltd - normal immunoglobulin 100 mg/ml - solution for infusion - 100 g/l - active: normal immunoglobulin 100 mg/ml excipient: glycine water for injection - replacement therapy indications: - primary immunodeficiency (pi) diseases - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment.
losec
pharmaco (nz) ltd - omeprazole 10mg (as the free base) - modified release capsule - 10 mg - active: omeprazole 10mg (as the free base) excipient: colloidal silicon dioxide dibasic sodium phosphate dihydrate gelatin hyprolose hypromellose iron oxide red lactose liquid paraffin macrogol 400 magnesium stearate mannitol methacrylic acid copolymer microcrystalline cellulose sodium laurilsulfate tekprint black sw-9008 titanium dioxide
losec
pharmaco (nz) ltd - omeprazole 20mg (as the free base) - modified release capsule - 20 mg - active: omeprazole 20mg (as the free base) excipient: colloidal silicon dioxide dibasic sodium phosphate dihydrate gelatin hyprolose hypromellose iron oxide red lactose liquid paraffin macrogol 400 magnesium stearate mannitol methacrylic acid copolymer microcrystalline cellulose sodium laurilsulfate tekprint black sw-9008 titanium dioxide
losec
pharmaco (nz) ltd - omeprazole 40mg (as the free base) - modified release capsule - 40 mg - active: omeprazole 40mg (as the free base) excipient: colloidal silicon dioxide dibasic sodium phosphate dihydrate gelatin hyprolose hypromellose iron oxide red lactose liquid paraffin macrogol 400 magnesium stearate mannitol methacrylic acid copolymer microcrystalline cellulose sodium laurilsulfate tekprint black sw-9008 titanium dioxide
losec mups
pharmaco (nz) ltd - omeprazole magnesium 41.3mg equivalent to 40 mg omeprazole - enteric coated tablet - 40 mg - active: omeprazole magnesium 41.3mg equivalent to 40 mg omeprazole excipient: crospovidone ferrous oxide glyceryl monostearate hard paraffin hyprolose hypromellose macrogol 6000 magnesium stearate methacrylic acid copolymer microcrystalline cellulose polysorbate 80 purified talc sodium hydroxide sodium stearyl fumarate sugar spheres titanium dioxide triethyl citrate - reflux oesophagitis